🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our #HERO consortium poster 4267 TODAY at #ASH23! We compared ATRA+ATO+GO vs ATRA+ATO+Ida in HR APL 🩸In real world, 69% of the GO arm required ida for cytoreduction (so not truly chemo free) 🩸🟰 efficacy 🩸🟰 composite safety, but ⬇️ duration of neutropenia in GO arm

What is the best treatment for high-risk APL? Are GO-based regimens better than APML4-style? 🤔 Check out our FIRST major multi-center hematology PharmD pub and find out! 👀 #leusm #apl #HEROconsortium onlinelibrary.wiley.com/doi/10.1002/aj…

Multicenter retrospective evaluation of treatment for high risk acute promyelocytic #leukemia: Comparison of the APML4 and ATRA+ATO+GO in high risk #APL conducted by the HERO Consortium Free access: doi.org/10.1002/ajh.27… #LeuSM Bernie Marini #HemOnc